{"query_echo":{"q":"","filters":{"analysis_type":["toxicological assessment"]},"warnings":[{"code":"facet_value_not_in_vocabulary","message":"Value 'toxicological assessment' for facet 'analysis_type' is not in the controlled vocabulary."}]},"total":{"value":3,"relation":"eq"},"page":1,"page_size":20,"self":"https://climateinsightsdirectory.org/api/v1/search?analysis_type=toxicological+assessment","stability":"beta","ai_marking":{"digital_source_type":{"uri":"http://cv.iptc.org/newscodes/digitalsourcetype/trainedAlgorithmicMedia","name":"Created using Generative AI"},"notice":"Summary and key insights are generated using artificial intelligence."},"results":[{"id":"capeca-000245","url":"https://climateinsightsdirectory.org/document/capeca-000245","title":"Request for Special Review of Mancozeb Under the Pest Control Products Act","publisher":{"name":"Canadian Association of Physicians for the Environment","organization":"canadian-association-of-physicians-for-the-environment"},"document_type":"statement","language":"en","date_published":"2023-11-07","source_url":"https://cape.ca/wp-content/uploads/2023/11/2023-11-07-request-for-SR-of-Mancozeb-revised.pdf#new_tab","generator":"Climate Insights Directory","generated_fields":["summary","key_insights","climate_tags","geography_discussed","analysis_type"],"summary":{"text":"The document argues that mancozeb and its metabolite ethylene thiourea (ETU) pose unacceptable risks to human health and the environment, citing a 2021 European Union ban and deficiencies in Canada's regulatory oversight. The requesters claim the PMRA has failed to implement its own 2020 risk mitigation measures, ignored critical biomonitoring data showing widespread ETU exposure in Canadians, and relied on outdated US water monitoring data to underestimate cancer risks. They specifically highlight risks of endocrine disruption, reproductive toxicity, and harm to non-target arthropods, birds, and aquatic organisms, demanding a special review and the suspension of product renewals.","ai_generated":true,"unit":"capeca-000245#summary","date_modified":"2026-10-23"},"key_insights":[{"text":"The requesters seek a special review under section 17(2) of the Pest Control Products Act (PCPA) because the European Union prohibited all uses of mancozeb in 2021, and a notification was given under the Rotterdam Convention in December 2022.","ai_generated":true,"unit":"capeca-000245#insight-1","date_modified":"2026-10-23"},{"text":"Mancozeb and its primary metabolite, ethylene thiourea (ETU), are linked to severe health effects, including thyroid hormone disruption, potential carcinogenic effects (specifically liver tumors), neurodevelopmental damage, and reproductive dysfunction.","ai_generated":true,"unit":"capeca-000245#insight-2","date_modified":"2026-10-23"},{"text":"The PMRA's 2020 re-evaluation decision required numerous risk reduction measures—including lower application rates, increased personal protective equipment, and restricted-entry intervals (REIs)—which the requesters claim have not been implemented on public labels as of September 2023.","ai_generated":true,"unit":"capeca-000245#insight-3","date_modified":"2026-10-23"}],"climate_tags":["water pollution","biodiversity"],"geography_discussed":["European Union","United States"],"frame_perspective":[],"analysis_type":["regulatory challenge","toxicological assessment"]},{"id":"client-000868","url":"https://climateinsightsdirectory.org/document/client-000868","title":"Resorcinol vote at the REACH Committee meeting of 22-23 September: support the adequate SVHC identification of this known endocrine disruptor for health","publisher":{"name":"ClientEarth","organization":"clientearth"},"document_type":"statement","language":"en","date_published":"2021-09-06","source_url":"https://www.clientearth.org/media/kqfjrg5m/resorc_2.pdf","generator":"Climate Insights Directory","generated_fields":["summary","key_insights","climate_tags","analysis_type"],"summary":{"text":"Civil society organisations are calling on the German government to support the classification of Resorcinol as a substance of very high concern (SVHC) under the REACH regulation. They argue that Resorcinol is a known endocrine disruptor that inhibits thyroperoxidase (TPO), affecting thyroid hormone levels essential for brain development, particularly in unborn children. The authors highlight that Resorcinol is a high-volume compound used in cosmetics, pharmaceuticals, and rubber products, leading to significant exposure for workers and the public. They contend that the substance meets the 'equivalent level of concern' (ELoC) criteria due to the irreversible nature of its developmental effects, such as hypothyroidism and neurological impacts.","ai_generated":true,"unit":"client-000868#summary","date_modified":"2026-10-23"},"key_insights":[{"text":"Resorcinol is identified as an endocrine disruptor that inhibits thyroperoxidase (TPO), an enzyme critical for thyroid hormone synthesis, which is essential for prenatal brain development.","ai_generated":true,"unit":"client-000868#insight-1","date_modified":"2026-10-23"},{"text":"Exposure to Resorcinol is linked to severe and potentially irreversible developmental effects in humans, including goiter, hypothyroidism, and neurological impacts in children.","ai_generated":true,"unit":"client-000868#insight-2","date_modified":"2026-10-23"},{"text":"Resorcinol is a high-volume chemical registered at 1,000-10,000 tons per year and is used in various consumer and industrial applications, including adhesives, resins, flame retardants, pharmaceuticals, hygiene products, cosmetics, and rubber products.","ai_generated":true,"unit":"client-000868#insight-3","date_modified":"2026-10-23"},{"text":"The authors argue that Resorcinol meets the 'equivalent level of concern' (ELoC) criteria under REACH article 57(f) because its effects on thyroid hormones severely impact long-term health and well-being and are not easily reversed.","ai_generated":true,"unit":"client-000868#insight-4","date_modified":"2026-10-23"}],"climate_tags":["public health"],"geography_discussed":[],"frame_perspective":[],"analysis_type":["policy advocacy","toxicological assessment"]},{"id":"client-000869","url":"https://climateinsightsdirectory.org/document/client-000869","title":"Resorcinol vote at the REACH Committee meeting of 22-23 September: support the adequate SVHC identification of this known endocrine disruptor for health","publisher":{"name":"ClientEarth","organization":"clientearth"},"document_type":"statement","language":"en","date_published":"2021-09-06","source_url":"https://www.clientearth.org/media/ioipoeza/resorc_3.pdf","generator":"Climate Insights Directory","generated_fields":["summary","key_insights","climate_tags","geography_discussed","analysis_type"],"summary":{"text":"The document argues that Resorcinol should be identified as a substance of very high concern (SVHC) under REACH article 57(f) because it is an endocrine disruptor that inhibits thyroperoxidase (TPO), affecting thyroid hormone levels. The authors highlight severe developmental risks for unborn children, including hypothyroidism and neurological impacts, and note that the substance is a high-volume compound used in cosmetics, pharmaceuticals, and rubber products. They contend that the substance meets the 'equivalent level of concern' (ELoC) criteria and that failure to identify it would undermine the EU Chemicals Strategy for Sustainability.","ai_generated":true,"unit":"client-000869#summary","date_modified":"2026-10-23"},"key_insights":[{"text":"Resorcinol is identified as an endocrine disruptor that inhibits thyroperoxidase (TPO), an enzyme essential for thyroid hormone synthesis, which can lead to severe developmental effects in humans such as hypothyroidism, goiter, and neurological impacts in children.","ai_generated":true,"unit":"client-000869#insight-1","date_modified":"2026-10-23"},{"text":"The substance is a high-volume compound with annual registrations between 1,000 and 10,000 tons, used in various consumer and industrial applications including cosmetics, hygiene products, pharmaceuticals, flame retardants, adhesives, resins, and rubber products.","ai_generated":true,"unit":"client-000869#insight-2","date_modified":"2026-10-23"},{"text":"The authors argue that Resorcinol meets the 'equivalent level of concern' (ELoC) criteria under REACH article 57(f) because its effects on prenatal brain development are severe, long-term, and irreversible.","ai_generated":true,"unit":"client-000869#insight-3","date_modified":"2026-10-23"},{"text":"A previous attempt to identify Resorcinol as an SVHC at the ECHA Member State Committee 70 in June 2020 failed because Member States could not reach unanimity regarding the equivalent level of concern (ELoC) criteria.","ai_generated":true,"unit":"client-000869#insight-4","date_modified":"2026-10-23"}],"climate_tags":["public health"],"geography_discussed":["European Union"],"frame_perspective":[],"analysis_type":["policy advocacy","toxicological assessment"]}]}